Cullinan Therapeutics, Inc. CGEM Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $75.08M-2.1% | $88.33M+6.4% | $103.34M+1.2% | $72.82M-36.7% | $76.66M+3.3% | ||
| $276.8M+21.8% | $289.56M-8.4% | $229.26M-51.8% | $192.66M-64.8% | $227.17M-36.7% | ||
| $361.41M+13.7% | $386.76M-6.7% | $342.24M-42.2% | $275.91M-59.3% | $317.77M-28.7% | ||
| $342K-43.7% | $421K-38.4% | $489K-35.7% | $569K-31.9% | $607K-33.5% | ||
| $402.98M-30.5% | $448.37M-27.9% | $484.13M-25.9% | $520.33M-23.6% | $579.68M+29.0% | ||
| $7.53M-13.9% | $8.43M-7.0% | $9.27M-6.1% | $9.66M+10.9% | $8.75M-9.2% | ||
| $35.15M+28.5% | $37.74M+23.1% | $32.76M+35.3% | $28.06M+19.5% | $27.35M+24.7% | ||
| $36.81M+32.2% | $39.64M+25.9% | $32.76M+29.0% | $28.18M+12.8% | $27.84M+17.2% | ||
| $6K0.0% | $6K0.0% | $6K0.0% | $6K0.0% | $6K+50.0% | ||
| -$637.78M-53.0% | -$588.12M-59.7% | -$537.41M-67.6% | -$486.8M-73.8% | -$416.74M-75.1% | ||
| —— | $408.73M-30.8% | $451.37M-28.1% | $492.15M-25.0% | $551.84M+29.6% | ||
| $402.98M-30.5% | $448.37M-27.9% | $484.13M-25.9% | $520.33M-23.6% | $579.68M+29.0% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Cullinan Therapeutics, Inc.'s total assets?
- Cullinan Therapeutics, Inc. (CGEM) holds $403.0M in total assets, down 30.5% year over year.
- How much cash does Cullinan Therapeutics, Inc. have?
- Cullinan Therapeutics, Inc. holds $75.1M in cash and equivalents.
- Can Cullinan Therapeutics, Inc. cover its short-term obligations?
- Its current ratio is 10.28 — current assets exceed current liabilities.
- Where does Cullinan Therapeutics, Inc.'s balance sheet data come from?
- Every line is extracted from Cullinan Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.